DOSE OF REALITY: Big Pharma’s True Track Record Is A Hard Pill To Swallow: Part VII
Feb 25, 2019
In advance of the U.S. Senate Committee on Finance hearing on February 26,… Read More
© 2026 CSRXP- All Rights Reserved
Blog Posts
“DOSE OF REALITY” Big Pharma’s True Track Record Is A Hard Pill To Swallow: Part VI
Feb 22, 2019
In advance of the U.S. Senate Committee on Finance hearing on February 26,… Read More
“DOSE OF REALITY” Big Pharma’s True Track Record Is A Hard Pill To Swallow: Part V
Feb 21, 2019
In advance of the U.S. Senate Committee on Finance hearing on February 26,… Read More
“DOSE OF REALITY” Big Pharma’s True Track Record Is A Hard Pill To Swallow: Part IV
Feb 20, 2019
In advance of the U.S. Senate Committee on Finance hearing on February 26,… Read More
“DOSE OF REALITY” Big Pharma’s True Track Record Is A Hard Pill To Swallow: Part III
Feb 19, 2019
In advance of the U.S. Senate Committee on Finance hearing on February 26,… Read More
DOSE OF REALITY: Big Pharma’s True Track Record Is A Hard Pill To Swallow – Part II
Feb 18, 2019
In advance of the U.S. Senate Committee on Finance hearing on February 26,… Read More
DOSE OF REALITY: Big Pharma’s True Track Record Is A Hard Pill To Swallow – Part I
Feb 15, 2019
As bipartisan momentum to hold Big Pharma accountable and take action on… Read More
They Said It! House Lawmakers Agree Bipartisan Action Needed To Bring Down Drug Prices
Feb 13, 2019
On Tuesday, the U.S. House Committee on Ways & Means held the third… Read More
What they’re Saying: Reactions to Congress’ Drug Pricing Hearings
Feb 2, 2019
On Tuesday, the U.S. House Oversight and Reform and Senate Finance Committees… Read More
THEY SAID IT! Drug Companies Have Been Warned
Jan 31, 2019
Drug Companies Have Been Warned: House & Senate Chairmen & Ranking… Read More
Second Opinion: R&D Is Not To Blame For Skyrocketing Drug Costs
Jan 17, 2019
The jig is up – a new report showsthat “the skyrocketing cost of many… Read More
Second Opinion: No, Big Pharma Is Not Changing
Jan 11, 2019
Right on cue, dozens of pharmaceutical companies rang in the new year by… Read More